Attention:
Card image cap

Antitrust Litigation: Class Certification Issues and Developments


Level: Advanced
Runtime: 57 minutes
Recorded Date: September 29, 2022
Click here to share this program
Printer-Friendly Version
Closed Caption

Agenda

Key topics include:
  • Antitrust Class Certification Trends and Developments
  • Emerging Class Certification Issues
  • Recent and Notable Court Decisions
  • Tips to Strengthen Your Antitrust Class Action Strategies
  • What Lies Ahead
Runtime: 1 hour
Recorded: September 29, 2022

For NY - Difficulty Level: For experienced attorneys only (nontransitional)
For NY - Difficulty Level: Experienced attorneys only (non-transitional)

Description

Prompted by the Biden administration’s aggressive focus on market competition, the past year has witnessed notable antitrust enforcement activities in several key industries. Furthermore, recurring debates over class certification standards continue to shake up the legal landscape for antitrust lawsuits.

As the antitrust agenda remains to become a top priority this year, policy changes are anticipated to open new challenges in handling class certification in antitrust cases. Thus, practitioners must closely track all trends and legislative developments that will create major shifts in the class certification process and litigation.

In this program, leading antitrust thought leaders Ralph E. Labaton (Haug Partners) and Hagai Doron (S. Horowitz & Co.) will provide an in-depth discussion of the latest and significant issues surrounding antitrust class certification. Speakers will also provide practical strategies in handling complex antitrust class claims.

This program was recorded on September 29, 2022.

Provided By

Card image cap The Knowledge Group
Card image cap

Panelists

Card image cap

Hagai Doron

Partner
S. Horowitz & Co.

Hagai Doron chairs S. Horowitz & Co.’s Antitrust & Competition Law Practice Group and is widely recognized as one of Israel’s leading antitrust lawyers.

Hagai’s extensive experience includes: advising on civil and criminal investigations by the Israel Competition Authority, challenging monopoly declarations, merger control, collaborative joint ventures, distribution strategy, cartels, dominance, licensing, and class actions involving breaches of Israeli antitrust law. In particular, Hagai acts for clients in damages and class action claims which seek substantial compensation following a finding, whether in the US, the EU or Israel, of a contravention of competition law.

Hagai also has substantial experience co-coordinating with foreign counsel on Israeli antitrust and merger clearances for global and cross-border mergers, joint ventures, strategic alliances and other collaborative arrangements.

Card image cap

Ralph E. Labaton

Associate
Haug Partners

Ralph E. Labaton is an attorney in the New York office of Haug Partners, where he focuses on antitrust litigation and other complex litigation matters. He has significant experience litigating class actions across multiple industries, including reverse payment or “pay-for-delay” pharmaceutical actions. In addition to managing his active caseload, Mr. Labaton also advises clients seeking to obtain and protect intellectual property rights, such as patents and trademarks.

Mr. Labaton earned his J.D. from Cornell Law School, where he earned the CALI Award for Excellence for his efforts in the Securities Law Clinic. Mr. Labaton earned his B.B.A., cum laude, from Baruch College, Zicklin School of Business.


Card image cap

Similar Courses

Card image cap
61 minutes
Addressing Consumer Class-Action & Mass Arbitration Challenges
Consumer class-action lawsuits pose significant challenges for businesses across various industries. As legal and regulatory landscapes continue to evolve, understanding how to effectively address and navigate these challenges becomes crucial for organizations to protect their reputation, minimize financial risks, and maintain a positive relationship with their customers. Join us in this informative session as expert panelists provide you with valuable insights and practical strategies to effectively address consumer class-action and mass arbitration challenges, and explore ways to proactively manage and mitigate potential legal threats.

Women, Influence & Power in Law Conference

$65

Add to Cart
Card image cap
74 minutes
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
58 minutes
Antitrust Merger Enforcement: Significant Regulatory Developments and Issues Explored
In this session, distinguished professionals in antitrust law and compliance Kail J. Jethmalani (Axinn, Veltrop & Harkrider LLP) and Liang Ding (DeHeng Law Offices) will provide an in-depth discussion of antitrust merger enforcement. They will also offer best compliance practices to prepare for a challenging compliance environment.

The Knowledge Group

$75

Add to Cart
Card image cap
54 minutes
Antitrust Merger Enforcement: What to Expect in 2024?
Join us to hear Liang Ding, Partner at DeHeng Law Offices, and Keith Klovers, Of Counsel at Wilson Sonsini, as they offer a comprehensive overview of anticipated developments, challenges, and strategies in the domain of antitrust merger enforcement in 2024. These speakers will provide powerful insights on staying ahead in a swiftly evolving business landscape.

The Knowledge Group

$75

Add to Cart
Previous Next